4//SEC Filing
Turka Laurence A. 4
Accession 0001104659-20-010063
CIK 0001709401other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 9:48 PM ET
Size
5.3 KB
Accession
0001104659-20-010063
Insider Transaction Report
Form 4
Turka Laurence A.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-01-31+350,000→ 350,000 totalExercise: $7.80Exp: 2030-01-30→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on January 21, 2021, then in 12 equal quarterly installments thereafter.
Documents
Issuer
Rubius Therapeutics, Inc.
CIK 0001709401
Entity typeother
Related Parties
1- filerCIK 0001800952
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 9:48 PM ET
- Size
- 5.3 KB